Institute of Chemical Biology &
Drug
Discovery

Organization of ICB&DD

ICB&DD is organized in conjunction with the Chemistry Department and the core laboratories, facilities, and offices are located in the Chemistry Building. However, its operation and management are independent of the Chemistry Department. It is essential for this "Center of Excellence" that the Director of ICB&DD directly reports to the University Executive Committee, i.e., Provost, Vice President for Research, and Vice President for the Health Sciences Center. Dr. Ojima, Distinguished Professor of Chemistry, serves as the founding Director of the institute. ICB&DD has core Members, Project Members, Steering Committee Members, and Advisory Board Members. The activities of the Director and Members will be reviewed every 5 years. In addition, there is a Laboratory Director for Bioanalytical Instrumentation (a Ph.D. chemist) as well as a Laboratory Director for Combinatorial Chemistry and Synthesis (a Ph.D. chemist) and his/her Technical Support Specialist (a B.S./M.S. chemist). Both Laboratory Directors of the ICB&DD facilities report to the Director of the Institute. ICB&DD will take the "Team Project" approach to attack major biomedical problems. Accordingly, Project Members and Advisory Board Members will be invited to participate in particular projects which may lead to a dynamic change in membership, contingent on the status of projects and necessary expertise. The current members of ICB&DD are as follows:

Director: Iwao Ojima (Distinguished Professor, Chemistry)

Steering Committee Members: James Bliska (Molecular Genomics and Microbiology), Carl Anderson (BNL), Wadie Bahou (SOM), Todd Miller (Physiology and Biophysics), Daniel Raleigh (Chemistry), Basil Rigas (Department of Preventive Medicine/ Pharmacological Sciences), Maria Ryan (Oral Biology and Pathology), Carlos Simmerling (Chemistry) Roy Steigbigel (SOM), Peter Tonge (Chemistry) and Stanley Zucker (SOM/VA).

Members: Nicole Sampson (Chemistry,) Daniel Raleigh (Chemistry), Peter Tonge (Chemistry), Carlos Simmerling (Chemistry), Francis Johnson (Pharmacological Sciences/Chemistry), Carlos de los Santos (Pharmacological Sciences), Robert Haltiwanger (Biochemistry and Cell Biology), Rob Rizzo (Applied Mathematics and Statistics), Orlando Scharer (Pharmacology/Chemistry). James Bliska (Molecular Genomics and Microbiology), Todd Miller (Physiology and Biophysics), Roy Steigbigel (SOM), Stanley Zucker (SOM/VA), Carl Anderson (BNL), Maria Ryan (Oral Biology and Pathology), Basil Rigas (Preventive Medicine/ Pharmacological Sciences), Wadie Bahou (SOM), Kenneth Shroyer (Pathology) and Subramanyam Swaminathan (BNL), Wen-Tien Chen (SOM, Medicine).

Project Members: Kathlyn Parker (Chemistry), Dale Drueckhammer (Chemistry), Jin Wang (Chemistry), Elizabeth Boon (Chemistry), Isaac Carrico (Chemistry), Howard Crawford (Pharmacology), Ralph Bernacki (Roswell Park Cancer Institute), David Green (Applied Mathematics & Statistics), Jian Cao (SOM, Oncology),Galina Botchkina (SOM, Surgical Oncology), Wei-Xing Zong (Molecular Genetics & Microbiology), Richard Lin (SOM, Hematology), Takushi Kaneko (Chemistry/TB Alliance Inc.), Lee Arnold (Chemistry/DiscoverElucidations, LLC), Stephen Walker (Oral Biology and Pathology), Balaji Sitharaman (Biomedical Engineering), Jingfang Ju (SOM, Pathology).

Advisory Board Members: Susan Horwitz (A. Einstein Coll. Med.), Richard Clark (Biomedical Engineering), John Kovach (Long Island Cancer Center), Wendy Cornnel (Director, Molecular Systems Modeling Group, Merck and Co), James Staros (Biochemistry and Cell Biology, Dean of CAS), John Piwinski (Schering-Plough), Robert Volkmann (Pfizer), William Murray (Johnson Pharmaceutical Research Institute), Ezio Bombardelli (Indena, SpA), Arlindo Castelhano (OSI Pharmaceuticals), Lorne Taichman (Oral Biology and Pathology), Timothy Kinsella, (SOM, Director of SBU Cancer Center).

Research Programs:

Structural and Computational Biology Program
Carlos Simmerling and Daniel Raleigh, Program Directors

Tuburculosis Related Research Program
Peter Tonge, Program Director

Cancer Research Program
Stanley Zucker, Program Director

ICB&DD Organizational Chart PDF

ICB&DD By Laws

Last Modified Friday, 30-Jan-2009 12:43:53 EST